Hepmarc: A 96 week randomised controlled feasibility trial of add-on maraviroc in people with HIV and non-alcoholic fatty liver disease.
Bradshaw D, Abramowicz I, Bremner S, Verma S, Gilleece Y, Kirk S, Nelson M, Housman R, Miras H, Orkin C, Fox A, Curnock M, Jennings L, Gompels M, Clarke E, Robinson R, Lambert P, Chadwick D, Perry N.
Bradshaw D, et al. Among authors: curnock m.
PLoS One. 2023 Jul 14;18(7):e0288598. doi: 10.1371/journal.pone.0288598. eCollection 2023.
PLoS One. 2023.
PMID: 37450478
Free PMC article.
Clinical Trial.